Literature DB >> 30039337

Genetic Analysis and Clinical Presentation in Silver Russell Syndrome.

Nikhil Lohiya1, Rashmi Lote-Oke2, Meenal Agarwal3, Nikhil Phadke3, Vaman Khadilkar4, Anuradha Khadilkar5.   

Abstract

Mesh：

Substances：

Year:  2018        PMID： 30039337     DOI： 10.1007/s12098-018-2738-5

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN： 0019-5456            Impact factor:   1.967


× No keyword cloud information.
  4 in total

1.  Height at start, first-year growth response and cause of shortness at birth are major determinants of adult height outcomes of short children born small for gestational age and Silver-Russell syndrome treated with growth hormone: analysis of data from KIGS.

Authors:  Michael B Ranke; Anders Lindberg
Journal:  Horm Res Paediatr       Date:  2010-04-30       Impact factor: 2.852

2.  Diagnosis and management of Silver-Russell syndrome: first international consensus statement.

Authors:  Emma L Wakeling; Frédéric Brioude; Oluwakemi Lokulo-Sodipe; Susan M O'Connell; Jennifer Salem; Jet Bliek; Ana P M Canton; Krystyna H Chrzanowska; Justin H Davies; Renuka P Dias; Béatrice Dubern; Miriam Elbracht; Eloise Giabicani; Adda Grimberg; Karen Grønskov; Anita C S Hokken-Koelega; Alexander A Jorge; Masayo Kagami; Agnes Linglart; Mohamad Maghnie; Klaus Mohnike; David Monk; Gudrun E Moore; Philip G Murray; Tsutomu Ogata; Isabelle Oliver Petit; Silvia Russo; Edith Said; Meropi Toumba; Zeynep Tümer; Gerhard Binder; Thomas Eggermann; Madeleine D Harbison; I Karen Temple; Deborah J G Mackay; Irène Netchine
Journal:  Nat Rev Endocrinol       Date:  2016-09-02       Impact factor: 43.330

3.  Growth and symptoms in Silver-Russell syndrome: review on the basis of 386 patients.

Authors:  H A Wollmann; T Kirchner; H Enders; M A Preece; M B Ranke
Journal:  Eur J Pediatr       Date:  1995-12       Impact factor: 3.183

4.  Long-term effects of growth hormone (GH) treatment on body composition and bone mineral density in short children born small-for-gestational-age: six-year follow-up of a randomized controlled GH trial.

Authors:  Ruben H Willemsen; Nicolette J T Arends; Willie M Bakker-van Waarde; Maarten Jansen; Edgar G A H van Mil; Jaap Mulder; Roelof J Odink; Maarten Reeser; Ciska Rongen-Westerlaken; Wilhelmina H Stokvis-Brantsma; Johan J J Waelkens; Anita C S Hokken-Koelega
Journal:  Clin Endocrinol (Oxf)       Date:  2007-06-11       Impact factor: 3.478
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.